Menjo, JP
Noboru Menjo, Miyota-Machi JP
Patent application number | Description | Published |
---|---|---|
20100308679 | MICRO ROTOR AND ROTARY ELECTRIC MACHINE INCORPORATING SAME - A micro rotor is disclosed and includes a plurality of circular or annular plate-shaped thick film magnets which each include an isotropic magnet with a thickness t | 12-09-2010 |
Noboru Menjo, Kitasaku-Gun JP
Patent application number | Description | Published |
---|---|---|
20090096561 | Rare earth bonded magnet and production method thereof - In order to achieve excellent heat resistance, durability and weatherability for use in an extended range of temperature environments, a rare earth bonded magnet is formed such that a material mixture comprising: a rare earth magnetic powder having a particle diameter ranging from 30 μm to 500 μm; a resin binder constituted by a thermosetting resin; and an organic phosphorous compound, is compression-molded and hardened, wherein the organic phosphorous compound is uniformly dispersed in the resin binder. | 04-16-2009 |
20100245006 | RARE EARTH BONDED MAGNET - A rare earth bonded magnet is provided which is produced such that a mixture which comprises: a rare earth magnet powder; a resin binder comprising a thermosetting resin; an organic phosphorus compound; and a coupling agent is compress-molded, heated and cured, wherein the organic phosphorus compound and the coupling agent are represented by the following respective chemical formulas (structural formulas): | 09-30-2010 |
20110266894 | MANUFACTURING METHOD OF LAMINATED MAGNET FILM WITH SELF-BONDING LAYER - There is provided the manufacturing method of a laminated magnet film, including the steps of: a first step of preparing a magnet film, 40 μm to 300 μm in thickness, provided with a nanocrystalline structure magnetically isotropic; a second step of applying a self-bonding resin composition with film formability on the magnet film preparing a self-bonding magnet film composed of the magnet film and a self-bonding layer; a third step of mechanically processing the self-bonding magnet film being solid or hollow; a fourth step of preparing the laminated magnet film by laminating the self-bonding magnet films; a fifth step of melting the self-bonding layer of the laminated magnet film and then cooling and solidifying the self-bonding layer to integrally rigidify the laminated magnet film; and a sixth step of magnetizing the rigidified laminated magnet film. | 11-03-2011 |
Noboru Menjo, Fukuroi-Shi JP
Patent application number | Description | Published |
---|---|---|
20130192723 | METHOD FOR MANUFACTURING BONDED MAGNET - A method for manufacturing a magnetized bonded magnet, including the steps of: arranging a magnetization permanent magnet for magnetizing a magnetic field near a non-magnetized bonded magnet; heating the non-magnetized bonded magnet to a temperature of a Curie point thereof or higher; and continuously magnetizing the magnetic field to the non-magnetized bonded magnet by the magnetization permanent magnet for magnetizing the magnetic field while cooling the non-magnetized bonded magnet reached at the temperature of the Curie point thereof or higher to a temperature of less than the Curie point, wherein the non-magnetized bonded magnet is a rare-earth iron bonded magnet including two or more different rare-earth elements in magnet powder thereof. | 08-01-2013 |
Nobuo Menjo, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20100004459 | 2-PHENYLNICOTINIC ACID DERIVATIVE - The present invention is to provide the compounds useful as a treating or preventing agent for gout and hyperuricemia which are 2-phenylnicotinic acid derivatives having a uric acid lowering action due to an excellent xanthine oxidase inhibitory action. Since the 2-phenylnicotinic acid derivatives of the present invention exhibit a uric acid lowering action due to an excellent xanthine oxidase inhibitory action and also hypolipemic action, their utility is very high as a treating or preventive agent for gout and hyperuricemia which are often accompanied by hyperlipemia as a complication. | 01-07-2010 |
Takeshi Menjo, Abiko-Shi JP
Patent application number | Description | Published |
---|---|---|
20100021194 | IMAGE FORMATION SYSTEM, IMAGE FORMATION METHOD, AND IMAGE QUALITY IMPROVEMENT METHOD - An image formation system includes image forming means for forming different color toner images on a recording material having a toner reception layer; first image heating means for heating and pressing the toner image on the recording material; second image heating means for heating and pressing the toner image on the recording material having been heated and pressed by the first image heating means; and wherein the first image heating means is operable so as to provide a granularity R of the toner image satisfying 0.5≦R≦4.0 and a glossiness G of the toner image satisfying 5≦G≦40, and the second image heating means is operable so as to provide a granularity R of the toner image satisfying not more than 4.0 and a glossiness G of the toner image satisfying not less than 60. | 01-28-2010 |
Yasuhiro Menjo, Tokushima-Shi JP
Patent application number | Description | Published |
---|---|---|
20110082110 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION - The present invention provides a benzoazepine compound represented by following general formula (1): | 04-07-2011 |
20110098250 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION - The present invention provides a benzoazepine compound represented by following general formula (1): | 04-28-2011 |
20120065162 | N-N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS - The present invention provides a pyrrolidine compound of General Formula (1) | 03-15-2012 |
20120277188 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION - The present invention provides a benzoazepine compound represented by following general formula (1): | 11-01-2012 |
20120277189 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION - The present invention provides a benzoazepine compound represented by following general formula (1): | 11-01-2012 |
20130203750 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS - The present invention provides a pyrrolidine compound of General Formula (1) | 08-08-2013 |
20140288065 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS - The present invention provides a pyrrolidine compound of General Formula (1) | 09-25-2014 |
Yasuhiro Menjo, Osaka JP
Patent application number | Description | Published |
---|---|---|
20100331317 | BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION - The present invention provides a novel benzodiazepine compound that blocks the I | 12-30-2010 |
20110071084 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 03-24-2011 |
20130040941 | BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION - The present invention provides a novel benzodiazepine compound that blocks the I | 02-14-2013 |
20140024619 | Benzazepine Derivatives Useful as Vasopressin Antagonists - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 01-23-2014 |
20140024640 | Benzazepine Derivatives Useful as Vasopressin Antagonists - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 01-23-2014 |
20140343277 | NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION - The present invention provides a novel diazepine compound that blocks the I | 11-20-2014 |
Yasuhiro Menjo, Tokushima JP
Patent application number | Description | Published |
---|---|---|
20090088406 | N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS - The present invention provides a pyrrolidine compound of General Formula (1) | 04-02-2009 |
20100004206 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION - The present invention provides a benzoazepine compound represented by following general formula (1): | 01-07-2010 |
20130331358 | Water-Soluble Benzoazepine Compound and Its Pharmaceutical Composition - The present invention provides a benzoazepine compound represented by following general formula (1): | 12-12-2013 |
Yasuhiro Menjo, Osaka-Shi JP
Patent application number | Description | Published |
---|---|---|
20120225866 | NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION - The present invention provides a novel diazepine compound that blocks the I | 09-06-2012 |
Yusuke Menjo, Chiyoda-Ku JP
Patent application number | Description | Published |
---|---|---|
20130110973 | PROGRAMMABLE LOGIC CONTROLLER | 05-02-2013 |